Hims & Hers Health, Inc. Financials

Market Capitalization $6.74 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	70.16
Forward PE	67.11
Price to Sales TTM	$5.43
Price to Book MRQ	$15.28
Enterprise to Revenue	5.55
Enterprise to EBITDA	115.31

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	8.15%
Operating Margin	5.57%
Return on Assets TTM	5.66%
Return on Equity TTM	26.35%

Income Statement

Revenue TTM	$1,241,993,984
Revenue per Share TTM	$5.80
Quarterly Revenue Growth	77.10%
Gross Profit TTM	$714,949,000
EBITDA	$56,592,000
Net Income to Common TTM	$101,258,000
Diluted EPS TTM	$0.44
Quarterly Earnings Growth YoY	77.13%

Balance Sheet

Total Cash MRQ	$254,071,008
Total Cash per Share MRQ	$1.16
Total Debt MRQ	$
Total Debt to Equity MRQ	2.58
Current Ratio MRQ	2.14
Book Value per Share MRQ	$2.02

Cash Flow

Operating Cash Flow TTM	$186,682,000
Levered Free Cash Flow TTM	$126,814,128

HIMS Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	210,100,992
Float Shares	189,041,238
Avg 10 Volume	15,146,996
Avg 30 Volume	None
Shares Short	39,517,672
Short Ratio	2.17
Short % of Shares	20.60%
% Held by Insiders	11.37%
% Held by Institutions	65.94%

Stock Price Summary

Beta	1.06
Fifty Two Week Low	$8.51
Fifty Two Week High	$35.02
Fifty Two Week Change	70.78%
Day 50 MA	$23.58
Day 200 MA	$18.54

Dividends and Splits

Forward Annual Dividend Rate	$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date